Cornerstone Capital Management’s Edwards Lifesciences EW Stock Holding History

Cornerstone Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,323,432	Closed	-$90.5M	–	47
2014 Q1	$90.5M	Sell	7,323,432 -771,978	-10%	-$8.91M	2.93%	9
2013 Q4	$88.7M	Buy	8,095,410 +988,044	+14%	+$11.1M	2.63%	11
2013 Q3	$82.5M	Sell	7,107,366 -73,500	-1%	-$860K	2.55%	13
2013 Q2	$80.4M	Buy	+7,180,866	New	+$85M	2.65%	12

Other funds holding EW

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cornerstone Capital Management's EW Position: Q2 2014 in Review

Cornerstone Capital Management sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 7,323,432 shares — an estimated $90.5M sold.

Cornerstone Capital Management first reported a position in EW in Q2 2013 and held it in 4 quarters. The position peaked at $90.5M in Q1 2014. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

Cornerstone Capital Management reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
Cornerstone Capital Management sold 7,323,432 Edwards Lifesciences shares in Q2 2014, an estimated $90.5M.
Cornerstone Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 4 quarters.
Cornerstone Capital Management's Edwards Lifesciences position peaked at $90.5M in Q1 2014.
429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Cornerstone Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.